Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
Español
English
Русский
中文
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
BLTE
#1036
Belite Bio, Inc American Depositary Shares
190.3
0
+2.05%
Sector:
Básica:
Profit Currency:
Rango diario
Rango anual
Cambio diario
+2.05%
Monthly Change
+13.89%
6 month change
+193.45%
Cambio anual
+229.75%
Cierres anteriores
186.4
8
Open
190.3
0
Bid
Ask
Low
190.3
0
High
190.3
0
Volumen
8
Markets
Acciones
Atención Sanitaria
BLTE
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2022
2023
2024
TTM
Key stats
Total common shares outstanding
24.9 M
29.15 M
31.83 M
—
Valuation ratios
Enterprise value
699.89 M
1.16 B
1.98 B
—
Price to earnings ratio
-47.3
-35.93
-53.47
—
Price to sales ratio
—
—
—
—
Price to cash flow ratio
-51.96
-38.11
65.92
—
Price to book ratio
14.34
12.57
13.21
—
Enterprise value to EBITDA ratio
—
—
—
—
Profitability ratios
Return on assets %
0.28
0.33
0.24
—
Return on equity %
0.3
0.35
0.25
—
Return on invested capital %
3 082.21
3 797.06
3 088.58
—
Gross margin %
—
—
—
—
Operating margin %
—
—
—
—
EBITDA margin %
—
—
—
—
Net margin %
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
Current ratio
20.35
24.76
24.31
—
Inventory turnover
—
—
—
—
Asset turnover
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
Debt to equity ratio
—
—
—
—
Long term debt to total assets ratio
0
—
—
—
Long term debt to total equity ratio
0
—
—
—
Per share metrics
Operating cash flow per share
0.57
1.12
0.96
—
EBIT per share
—
—
—
—
EBITDA per share
—
—
—
—
Total debt per share
—
—
—
—
Cash per share
2.11
3.32
4.75
—
Net current asset value per share
2.14
3.38
4.82
—
Tangible book value per share
2.08
3.4
4.77
—
Working capital per share
2.04
3.25
4.62
—
Book value per share
2.08
3.4
4.78
—
Noticias
Belite Bio stock hits all-time high at 177.28 USD
H.C. Wainwright reitera calificación de Compra para Belite Bio con objetivo de 185 dólares
H.C. Wainwright mantiene calificación de Compra para Belite Bio con objetivo de $185
H.C. Wainwright reiterates Buy rating on Belite Bio stock with $185 target
Belite Bio completa la inscripción en el ensayo de medicamento para STGD1 fase 2/3
Belite Bio completes enrollment in phase 2/3 STGD1 drug trial
Las acciones de Belite Bio alcanzan máximos históricos a 170,35 dólares
Acciones de Belite Bio alcanzan un máximo histórico de $170.35
Belite Bio stock hits all-time high at $170.35
BofA Securities inicia cobertura de acciones de Belite Bio con calificación de Compra
BofA Securities inicia cobertura de Belite Bio con calificación de Compra
BofA Securities initiates coverage on Belite Bio stock with Buy rating